Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Amryt Pharma plc, a biopharmaceutical company, develops and commercializes therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is based in London, the United Kingdom.




Drug Manufacturers—Specialty & Generic


Amryt Pharma plc Dept 920A 196 High Road Wood Green London N22 8HH United Kingdom



44 20 3026 7257

Leave a comment

Your email address will not be published. Required fields are marked *